Lab supplies

This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Quality Biological Inc., a woman-owned, minority-owned small disadvantaged business located in Gaithersburg, Maryland. The contract, valued at $10,758.06 with a firm fixed price structure, covers laboratory supplies and was awarded on November 20, 2019, with an ultimate completion date of November 30, 2019. The place of performance is Derwood, Maryland. No set-aside designation was used for this award, reflecting Quality Biological Inc.'s competitive standing in the federal procurement marketplace. This procurement is part of the company's larger $100 million single-award BPA with NIH's Office of Logistics and Acquisition Operations, which provides comprehensive laboratory materials and services including reagents, media, lab plastics, consumables, blood products, biological materials, and laboratory testing services to support research programs across various NIH institutes and centers.

Quality Biological Inc. has established itself as a critical supplier of scientific and medical materials to federal agencies through its extensive portfolio of laboratory products and research support services. The company specializes in producing custom and standard cell culture, molecular biology reagents, buffers, and liquid solutions that are essential to biomedical and research initiatives. Beyond its primary relationship with NIH, Quality Biological Inc. maintains a $2 million multiple-award indefinite delivery contract with the Defense Logistics Agency Troop Support Medical group, supplying laboratory consumables such as centrifuge tubes, pipettes, cell culture flasks, and reagent reservoirs. The company has also demonstrated research capabilities through federal grant funding, including a significant Small Business Innovation Research grant from the National Heart Lung and Blood Institute focused on optimizing ex vivo 3-dimensional culture conditions for human hematopoietic stem cells.